Zhang Zhizhen, Li Shiyou
National Center for Pharmaceutical Crops, Arthur Temple College of Forestry and Agriculture, Stephen F. Austin State University, Nacogdoches, Texas 75962-6109, USA.
Phytochemistry. 2007 Aug;68(15):2075-86. doi: 10.1016/j.phytochem.2007.05.020. Epub 2007 Jun 27.
Continued chemical investigation on the fruits of North American Aesculus pavia L. resulted in the isolation and identification of 13 polyhydroxyoleanene pentacyclic triterpenoid saponins, named aesculiosides IIe-IIk (1-7), and IIIa-IIIf (8-13), together with 18 known compounds: aesculiosides Ia-Ie (14-18), IIa-IId (19-22), IVa-IVc (23-25), 3-O-[beta-D-galactopyranosyl(1-->2)]-alpha-L-arabinofuranosyl(1-->3)-beta-D-glucuronopyranosyl-21,22-O-diangeloyl-3beta,15 alpha,16 alpha,21 beta,22 alpha,28-hexahydroxyolean-12-ene (26), 3-O-[beta-D-glucopyranosyl(1-->2)]-alpha-L-arabinofuranosyl(1-->3)-beta-D-glucuronopyranosyl-21,22-O-diangeloyl-3beta,16 alpha,21 beta,22 alpha,24 beta,28-hexahydroxyolean-12-ene (27), 3-O-[beta-D-galactopyranosyl(1-->2)]-alpha-L-arabinofuranosyl(1-->3)-beta-D-glucuronopyranosyl-21,22-O-diangeloyl-3beta,16 alpha,21 beta,22 alpha,28-pentahydroxyolean-12-ene (28), R(1)-barrigenol (29), scopolin (30), and 5-methoxyscopolin (31). The structures of these compounds were elucidated by spectroscopic and chemical analyses. Compounds 14-22 and 26-28 were tested in vitro for their activity against 59 cell lines from nine different human cancers including leukemia, non-small cell lung, colon, CNS, melanoma, ovarian, renal, prostate, and breast. It was found that compounds with two-acyl groups at C-21 and C-22 had cytotoxic activity for all cell lines tested with GI(50) 0.175-8.71 microM, while compounds without acyl groups at C-21 and C-22 had weak or no cytotoxic activity. These results suggest that the acyl groups at C-21 and C-22 are essential for their activity.
对北美红花七叶树果实持续进行化学研究,结果分离并鉴定出13种多羟基齐墩果烷型五环三萜皂苷,命名为七叶皂苷IIe-IIk(1-7)和IIIa-IIIf(8-13),同时还有18种已知化合物:七叶皂苷Ia-Ie(14-18)、IIa-IId(19-22)、IVa-IVc(23-25)、3-O-[β-D-吡喃半乳糖基(1→2)]-α-L-阿拉伯呋喃糖基(1→3)-β-D-葡萄糖醛酸吡喃糖基-21,22-O-二当归酰基-3β,15α,16α,21β,22α,28-六羟基齐墩果-12-烯(26)、3-O-[β-D-吡喃葡萄糖基(1→2)]-α-L-阿拉伯呋喃糖基(1→3)-β-D-葡萄糖醛酸吡喃糖基-21,22-O-二当归酰基-3β,16α,21β,22α,24β,28-六羟基齐墩果-12-烯(27)、3-O-[β-D-吡喃半乳糖基(1→2)]-α-L-阿拉伯呋喃糖基(1→3)-β-D-葡萄糖醛酸吡喃糖基-21,22-O-二当归酰基-3β,16α,21β,22α,28-五羟基齐墩果-12-烯(28)、R(1)-巴里甾醇(29)、东莨菪苷(30)和5-甲氧基东莨菪苷(31)。通过光谱和化学分析阐明了这些化合物的结构。对化合物14-22和26-28针对包括白血病、非小细胞肺癌、结肠癌、中枢神经系统癌、黑色素瘤、卵巢癌、肾癌、前列腺癌和乳腺癌在内的9种不同人类癌症的59种细胞系进行了体外活性测试。发现C-21和C-22位带有两个酰基的化合物对所有测试细胞系均具有细胞毒性活性,GI(50)为0.175 - 8.71微摩尔,而C-21和C-22位没有酰基的化合物具有较弱的细胞毒性活性或无细胞毒性活性。这些结果表明C-21和C-22位的酰基对其活性至关重要。